• Start to finish partner in for Diagnostics
• Clinical trial support (GLP, GCLP)
• Technology and platform agnostic
• Cost-effective, risk-mitigated approach and clear strategic guidance
• Precision medicine, Biomarker driven patient stratification
• Regulatory expertise (IDE, Q-sub, 510(k), De Novo, PMA (single site and full IVD), BIMO)
• Orthogonal method validation, multi-site validation studies, and head to head assay comparisons
• CLIA/CAP consulting and Bioincubator program

Come talk to us. Call (866) 225-9195 or fill out this form.